-
DEPARTMENT OF HEALTH
NOTICE OF FINAL RULEMAKING
The Interim Director of the Department of Health, pursuant to the authority set forth in Section 4 of the District of Columbia Newborn Screening Requirement Act of 1979, effective April 29, 1980 (D.C. Law 3-65; D.C. Official Code § 7-833 (2008 Repl.)), and Mayor's Order 2004-172, dated October 20, 2004, hereby gives notice of final rulemaking action to adopt the following amendments to Title 22-B of the District of Columbia Municipal Regulations (DCMR). The Interim Director took final rulemaking action on January 24, 2013. A Notice of Proposed Rulemaking was published December 14, 2012, at 59 DCR 14826. No comments were received in connection with the proposed rule, and no changes have been made since publication of the proposed rule. These rules will become effective upon publication of this notice in the D.C. Register.
The final rule amends Section B-2101.1 to add a metabolic disorder to the panel of tests that hospitals and birthing centers must make available to parents of newborns, and amends Section 2199 to add a definition for a metabolic disorder.
Title 22-B (Public Health and Medicine) of the DCMR is amended as follows:
Section 2101.1 of Chapter 21 (Neonatal Screening Services) is amended by adding a new subsection (oo) and amending subsections (mm) and (nn) to read as follows:
(mm) Tyrosinemia type I (TYR I);
(nn) Very long-chain acyl-CoA dehydrogenase deficiency (VLCAD); and
(oo) Severe Combined Immunodeficiency (SCID).
Section 2199.1 is amended by adding the following term with the ascribed meaning as follows:
Severe Combined Immunodeficiency (SCID) -- a primary immunodeficiency disease that affects infants lacking T lymphocytes, the white blood cells that help resist infections. Babies with this disease are born healthy and identified only after they begin to suffer from severe infections. SCID affects a minimum of one in 100,000 newborns.
